Literature DB >> 7015601

Use of indium-111-labeled cells in measurement of cellular dynamics of experimental cardiac allograft rejection.

S Oluwole, T Wang, R Fawwaz, K Satake, R Nowygrod, K Reemtsma, M A Hardy.   

Abstract

This study evaluates the kinetics and utility of infused indium-111-labeled cells in detecting rejection in ACI to Lewis rat heart allografts. Syngeneic leukocytes, lymph node lymphocytes, and platelets were isolated and labeled with indium-111 (111In) oxine, respectively, and were infused i.v. into Lewis rats carrying beating ACI or syngeneic hearts from post-transplant days 0 to 6. Recipients were imaged serially at 24 hr after infusion of labeled cells followed by excision of both native and transplanted hearts for direct isotope count. Labeled leukocytes accumulative progressively in the allograft with the scan becoming positive by post-transplant day 4. The ratio of allograft to native heart isotope counts rose from 1.25 on day 1 to 10.07 (P less than 0.0001) on day 7. The Lewis recipients infused with labeled lymphocytes showed a positive scan on days 6 and 7 whereas the allograft to native heart isotope count ratio rose from 0.97 on day 1 to 5.33 (P less than 0.001) on day 7. Recipients infused with 111In-labeled platelets showed a positive scan on days 5 to 7 and the allograft to native heart isotope count ratio rose sharply from 2.56 on day 4 to 16.98 (P less than 0.005) on day 7. Syngeneic heart grafts failed to demonstrate significant accumulation of any of the labeled cell population. These studies confirm the importance of nonlymphocytic cells in cellular rejection, evaluate the kinetics of graft invasion by the various cell types, and suggest that the techniques used afford a method for a safe and an early detection of allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7015601     DOI: 10.1097/00007890-198101000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection.

Authors:  Guanfang Shi; David J Field; Kyung-ae Ko; Sara Ture; Kalyan Srivastava; Scott Levy; M Anna Kowalska; Mortimer Poncz; Deborah J Fowell; Craig N Morrell
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

2.  Platelets contribute to allograft rejection through glutamate receptor signaling.

Authors:  AnneMarie F Swaim; David J Field; Karen Fox-Talbot; William M Baldwin; Craig N Morrell
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

3.  Personalized risk predictor for acute cellular rejection in lung transplant using soluble CD31.

Authors:  Philippe Montravers; Giuseppina Caligiuri; Alexy Tran-Dinh; Quentin Laurent; Guillaume Even; Sébastien Tanaka; Brice Lortat-Jacob; Yves Castier; Hervé Mal; Jonathan Messika; Pierre Mordant; Antonino Nicoletti; Ian Morilla
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

4.  The use of 111In-labeled lymphocyte imaging to evaluate graft rejection following cardiac transplantation in dogs.

Authors:  J H McKillop; J Wallwork; B A Reitz; M E Billingham; R Miller; I R McDougall
Journal:  Eur J Nucl Med       Date:  1982

5.  Clinical usefulness of 111In-oxine-labeled autologous lymphocytes in kidney-graft rejection.

Authors:  J Martin-Comin; M Roca; J M Griñó; C Paradell; A Caralps
Journal:  Eur J Nucl Med       Date:  1985
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.